Literature DB >> 1455081

Subretinal perfluorocarbon liquids. An experimental study.

J M de Queiroz1, J C Blanks, S A Ozler, D V Alfaro, P E Liggett.   

Abstract

Perfluorocarbon liquids (PFCL) are fully fluorinated, synthetic, transparent compounds with a high specific gravity. These compounds are being increasingly used as an intraoperative tool for repair of complicated retinal detachments. A known complication of their use, however, is liquid entering the subretinal space via a retinal break. The purpose of this study was to evaluate the effects of two of these liquids when placed subretinally in the rabbit eye. Vitrectomy, retinotomy, and subretinal injection of 0.03 cc of either perfluoroctane, perfluorotributylamine, or balanced salt solution (control eyes) were performed on 36 rabbit eyes. Animals were monitored clinically by indirect ophthalmoscopy and fundus photography for up to 21 days. After the 21-day observation period, electroretinograms (ERG) were taken before the rabbits were killed. Histopathologic studies were done at 3 hours, 24 hours, 3 days, 7 days, 14 days, and 21 days after injection. Three eyes demonstrated tearing of the retinotomy site due to downward migration of the PFCL droplet. Results of the ERGs were normal in all animals tested. Phagocytosis of PFCL droplets by the retinal pigment epithelium (RPE) was observed in 1 eye 3 hours after injection. Three of the eyes that received PFCL injections and all of the control eyes demonstrated moderate intracellular edema of both inner and outer nuclear layers as early as 24 hours after injection. In one eye injected with PFCL, these changes progressed to swelling and cystic formation of the inner nuclear layer and mild degeneration of the outer photoreceptor segments 3 days after injection. It was assumed that these effects occurred on a mechanical basis and were not related to PFCL toxicity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1455081

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells.

Authors:  Adarsha Koirala; Rasha S Makkia; Mark J Cooper; Muna I Naash
Journal:  Biomaterials       Date:  2011-09-01       Impact factor: 12.479

Review 2.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

3.  Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Y Imamura; M Minami; M Ueki; B Satoh; T Ikeda
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

4.  Natural History of a Large Bubble of Migratory Submacular Perfluorocarbon.

Authors:  Ogugua Ndubuisi Okonkwo; Dennis Sibanda; Toyin Akanbi; Adekunle Olubola Hassan
Journal:  Int Med Case Rep J       Date:  2020-10-07

5.  COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS.

Authors:  Barbara Parolini; Dilraj S Grewal; Sajish J Pinackatt; Andrea Baldi; Attilio Di Salvatore; Gianluca Besozzi; Alessandro Finzi; Daniele Cardillo; Tamer H Mahmoud
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

6.  Surgery for CNV and autologous choroidal RPE patch transplantation: exposing the submacular space.

Authors:  Matteo Giuseppe Cereda; Barbara Parolini; Elisa Bellesini; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-03       Impact factor: 3.117

7.  The Effect of Temperature Changes in Vitreoretinal Surgery.

Authors:  Mario R Romano; Vito Romano; Alessandro Mauro; Martina Angi; Ciro Costagliola; Luigi Ambrosone
Journal:  Transl Vis Sci Technol       Date:  2016-02-09       Impact factor: 3.283

8.  DNA nanoparticles are safe and nontoxic in non-human primate eyes.

Authors:  Ryan A Kelley; Shannon M Conley; Rasha Makkia; Jamie N Watson; Zongchao Han; Mark J Cooper; Muna I Naash
Journal:  Int J Nanomedicine       Date:  2018-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.